Reuters logo
BRIEF-iCo Therapeutics says will hold pre IND meeting with division of transplantation & ophthalmology, U.S. FDA
2017年6月15日 / 晚上8点32分 / 3 个月前

BRIEF-iCo Therapeutics says will hold pre IND meeting with division of transplantation & ophthalmology, U.S. FDA

June 15 (Reuters) - iCo Therapeutics Inc

* Says it will hold a pre IND meeting with division of transplantation and ophthalmology, US FDA on June 21, 2017

* Says discussions will focus on a proprietary dual action Glaucoma Asset with a Novel mechanism of action that reduces intraocular pressure Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below